Prognostic Significance of p16 Protein Expression in Breast Cancer

In Vivo. 2022 Jan-Feb;36(1):336-340. doi: 10.21873/invivo.12707.

Abstract

Background/aim: Breast cancer is the most common cancer in Sudan. The p16 protein plays a vital role in the regulation of the cell cycle.

Patients and methods: This study analysed the protein expression of p16 in 202 paraffin blocks from Sudanese women with breast cancer using immunohistochemistry.

Results: This study included 168 (83.2%), 16 (7.9%), and 18 (8.9%) patients with invasive ductal carcinoma, invasive lobular carcinoma, and papillary carcinoma, respectively. There were 95 cases (47.0%) with grade III, 70 cases (34.6%) with grade II, and 23 cases (11.4%) with grade I breast cancer. The hormone receptor status was available for 119 of the cases, and 31 (15.3%), 25 (12.4%), and 63 (31.2%) cases were positive for oestrogen, progesterone, and HER2 receptors, respectively.

Conclusion: p16 protein expression was associated with high histologic grade, lymph node metastasis, and poor prognosis. p16 protein expression may potentially be used as a prognostic marker.

Keywords: Sudanese women; breast cancer; p16 protein expression.

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms* / genetics
  • Carcinoma, Ductal, Breast* / genetics
  • Female
  • Humans
  • Prognosis
  • Receptor, ErbB-2 / genetics
  • Receptors, Progesterone / genetics

Substances

  • Biomarkers, Tumor
  • Receptors, Progesterone
  • Receptor, ErbB-2